Publications Office of the EU
Portugal-Angra do Heroísmo: Pharmaceutical products - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

Portugal-Angra do Heroísmo: Pharmaceutical products

Overview
  • Awarded
    01/07/2022
  • Today
    22/08/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Hospital de Santo Espírito da Ilha Terceira, E. P. E. R.
Place of performance
NUTS code: PT200 Região Autónoma dos Açores
Location of buyer
NUTS code: PT200 Região Autónoma dos Açores
Business sector (Main CPV)
33600000 Pharmaceutical products
Total estimated contract value (excluding VAT)
377,168.52
Total final contract value (excluding VAT)
377,168.52 EUR
Procedure details
Tender reference number
51/0017/2022
Description

Fornecimento de Ipilimumab e Nivolumab ao Hospital de Santo Espírito da Ilha Terceira, EPER

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
PT200 Região Autónoma dos Açores
CPV code

33600000 - Pharmaceutical products

Award method
Lowest price
Estimated value
377,168.52
Final contracted value
377,168.52 EUR
Award of contract
Official name: Bristol Myers Squibb Farmacêutica Portuguesa, SA
Postal address: Rua Cláudio Galeno, edíficio Alloga, Cabra Figa
Town: Rio de Mouro
Postal code: 2635-154
Country: PRT
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.